Membership and Insurance
News and Advocacy
MedEffect Canada Notices
If you have trouble accessing any of the information in this OPA Bulletin, or if you have questions about any of the information contained in the bulletin, please email the OPA communications department.
OPA Membership Renewal is Now Open - Renew for 2017 Today!
Thank you for being an OPA member in 2016! Your membership and insurance expire on December 31, 2016 – renew today to ensure your continued access to the support and benefits that membership offers.
Early Bird Offer: Renew on or before December 15, 2016, and you’ll automatically be entered into a draw to receive an OPA Conference 2017 pass*!
As an OPA member, you get:
- Exclusive access to OPA’s best-in-class insurance programs which are designed to protect you, your family and your practice (watch our video to find out more)
- Up to 50 per cent off the non-member rate on OPA’s professional development programs – all of which have been designed to help you translate knowledge into practice and apply your learnings immediately
- NEW: Access to OPA’s Practice Support Network which lets you access OPA’s team of experts to help answer questions about policy and practice
- Associate membership with the Canadian Pharmacists Association
- Free subscriptions to RxFiles.ca, the Ontario Pharmacist magazine, and the Canadian Pharmacists Journal
- A 10 per cent discount on subscriptions to the Pharmacist’s Letter Canada and the Pharmacy Technician’s Letter Canada
- Discounts on a variety of practice and lifestyle benefits.
Find out more.
Your 2016 membership and insurance expire on December 31, 2016. Renew today to avoid any gaps in your insurance coverage and your member benefits access.
*Does not include accommodation or transportation.
**Some restrictions apply.
Back to top
Get Great Rates with OPA's Home and Auto Coverage
Looking for great home and auto insurance rates? Interested in fast and convenient service?
Get a free obligation quote today - click here for an auto quote, and click here for a home quote, or call COSECO at 1-888-394-4964.
Plus, by getting a quote, you could be entered into COSECO’s Home Auto Insurance Contest for the chance to win a grand prize of $2,500!
Back to top
Pharmacist’s Letter Canada: Avoid Anticoagulation Mishaps in Your A Fib Patients
Many atrial fibrillation patients aren’t getting appropriate anticoagulation with warfarin or a direct oral anticoagulant (DOAC). In fact, less than half of high-risk atrial fib patients at high stroke risk are on an anticoagulant.
Hear the new recommendations from frontline providers in a 20-minute webinar from Pharmacist’s Letter Canada, including answers to these questions:
- Which atrial fib patients are likely to benefit from anticoagulation?
- Which anticoagulant is preferred for atrial fib?
- When should warfarin be used instead of a DOAC?
- Are antiplatelet agents appropriate to lower stroke risk in atrial fib?
Interested in a subscription to Pharmacist’s Letter Canada
? For 2017, all OPA members get 10 per cent off the advertised 2017 subscription rate to Pharmacist’s Letter Canada
and Pharmacy Technician’s Letter Canada! Find out more
Back to top
Urgent Information Regarding the Long-Term Care Medication Management Initiative: Introduction of PINs on December 1, 2016, to Track Prescriber Responses to Recommendations
Note: This message is for pharmacies providing services to residents of long-term care homes. This initiative does not apply to claims for residents of retirement homes.
Pharmacists working in the LTC sector will recall that the Long-Term Care Medication Management Initiative was launched in early September 2016 with the goals of improving medication management in long-term care homes (LTCHs) and supporting the quality of care delivered to residents through the increased use of safe, effective, and lower-cost medications within the same therapeutic categories. A critical component of any study, including demonstration projects, is measurement and evaluation, and as such, it is important that we track the outcomes of the various interventions and decisions being made in order to confirm if the project has been appropriately structured. To assist in the evaluation of prescribing behaviours, the Ministry of Health and Long-Term Care has agreed to enable LTC pharmacy providers to track and capture outcomes through the use of four PINs.
For full details, click here.
Representatives from Neighbourhood Pharmacy Association of Canada and the Ontario Pharmacists Association will be meeting regularly with the Ministry to track PIN utilization and will incorporate this information into the project measurement and evaluation process for overall analysis. For any questions or comments as they relate to the application of these PINs for the demonstration project, please email us.
Back to top
Information on the 2016-17 Universal Influenza Immunization Program (UIIP) Vaccine Distribution Pilot for Pharmacists Outside of Toronto
As you may know, the Ministry of Health and Long-Term Care has implemented an influenza vaccine distribution pilot for pharmacists outside of Toronto for the 2016-17 Universal Influenza Immunization Program (UIIP). The purpose of this pilot is to identify opportunities to standardize vaccine delivery methods across the province and to improve the timeliness of influenza vaccine ordering and delivery timelines. As part of this pilot, pharmacies outside of Toronto that are approved by the Ministry to participate in the 2016-17 UIIP can place orders for publicly funded influenza vaccine with their wholesale distributor (i.e., Kohl & Frisch, McKesson, McMahon or Shoppers Drug Mart).
The Ministry has provided a question and answer document that will address the most frequently asked questions that the Ontario Pharmacists Association has received from members. In the document, you will also find at table that shows the number of doses given to distributors, the number of doses administered by pharmacies outside of Toronto, and the remaining doses at the distributors or at pharmacies. In addition, the Ministry has provided the attached table, which describes the publicly funded influenza vaccines that are available through the 2016-17 UIIP and the recommended age groups.
Please also note the following:
- TIV (Agriflu, Fluviral, Influvac) vaccines are considered equivalent with respect to their approved indications for use.
- QIV (FluLaval Tetra, Fluzone Quadrivalent) vaccines are considered equivalent with respect to their approved indications for use.
- Only Agriflu and Fluviral can be used as the TIV to immunize individuals who are 6 months to 18 years of age.
- Influvac can only be used for the immunizations of individuals 18 years of age and older.
- All influenza vaccines must be administered by a regulated healthcare professional.
- Publicly funded vaccine must not be administered to individuals outside the eligibility criteria or to individuals with contraindications to the vaccine.
- Trained pharmacists may only administer publicly funded vaccine to individuals 5 years of age and older.
- Your wholesaler may not have every vaccine product available for ordering. If the TIV and/or QIV vaccine you would like is not available, order another available TIV and/or QIV vaccine. For example, if Influvac is not available, order another available TIV vaccine (Agriflu or Fluviral) instead.
More information about the 2016-17 UIIP can be found on the Ministry's website here. For the French site, click here.
For any questions or if you’re experiencing any challenges with the process, please contact us.
Back to top
Paperless Drug Card Initiative Update: French References and Tools
Following the November 17, 2016 eblast in which OPA provided a number of references and tools to assist pharmacists in the implementation of the Paperless Drug Card Initiative, OPA received French versions for all five documents:
The Ontario Pharmacists Association would like to remind members that as of December 1, 2016, social assistance clients will no longer receive a monthly drug card. However, in situations where coverage must be confirmed and the SAV Helpline is not available, November cards can be accepted as proof of eligibility for the month of December only. Members who have additional questions about the Paperless Drug Card Initiative are encouraged to contact OPA.
Back to top
Are You Up to Date With the Enhanced MedsCheck Program?
Make sure you're ready to deliver the enhanced MedsCheck program - register for OPA's new MedsCheck Refresh: Implementing the Revitalized Program today!
This online program focuses on the key changes in the MedsCheck program and how they can be operationalized in the pharmacy. The goal is to provide practical recommendations to ensure that all MedsChecks are done effectively and efficiently. The program’s three modules will provide you with tips to help translate the knowledge you obtain from the presentations into your everyday practice. Samples of completed documentation forms will be provided.
Back to top
Learn How to Assess and Prescribe for Over 30 Conditions with OPA and CPhA's Assessing and Prescribing for Minor Ailments Online Program
This comprehensive program, developed in collaboration with the Canadian Pharmacists Association, covers a wide variety of minor ailments including dermatological, gastrointestinal, respiratory, musculoskeletal, and ocular conditions plus much more. Each module includes information about patient assessment, differential diagnosis, when to refer, treatment alternatives (including prescription drugs), treatment algorithms, monitoring and follow-up.
This program is supported in part by an unrestricted educational grant from Teva.
Back to top